Skip to main content
lexblog.com/lib/MMXN4BMZviewrecordjson
LEX-WK-MMXN4BMZcrawled 2026-06-24 10:50Z

PTAB Reaffirms Broad Institute Priority in CRISPR-Cas9 Interference No. 106, 115: What the Decision Signals for Biotech Innovation and Patent Strategy

Anh-Thu Lam · R. Danny Huntington · PTAB Law Blog · Published June 24, 2026

Work details

firm or organization
Rothwell Figg
publication
PTAB Law Blog
published
2026-06-24

Citation

Anh-Thu Lam, R. Danny Huntington, PTAB Reaffirms Broad Institute Priority in CRISPR-Cas9 Interference No. 106, 115: What the Decision Signals for Biotech Innovation and Patent Strategy, PTAB Law Blog (June 24, 2026) [The Library at LexBlog, LEX-WK-MMXN4BMZ, lexpid.org/MMXN4BMZ]